131 related articles for article (PubMed ID: 18535616)
1. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck.
Michaluart P; Abdallah KA; Lima FD; Smith R; Moysés RA; Coelho V; Victora GD; Socorro-Silva A; Volsi EC; Zárate-Bladés CR; Ferraz AR; Barreto AK; Chammas MC; Gomes R; Gebrim E; Arakawa-Sugueno L; Fernandes KP; Lotufo PA; Cardoso MR; Kalil J; Silva CL
Cancer Gene Ther; 2008 Oct; 15(10):676-84. PubMed ID: 18535616
[TBL] [Abstract][Full Text] [Related]
2. Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients.
Victora GD; Socorro-Silva A; Volsi EC; Abdallah K; Lima FD; Smith RB; Moyses RA; Zárate-Bladés CR; Michaluart P; Silva CL; Kalil J; Coelho V
Cancer Gene Ther; 2009 Jul; 16(7):598-608. PubMed ID: 19197326
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.
Gleich LL; Gluckman JL; Nemunaitis J; Suen JY; Hanna E; Wolf GT; Coltrera MD; Villaret DB; Wagman L; Castro D; Gapany M; Carroll W; Gillespie D; Selk LM
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):775-9. PubMed ID: 11448348
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy for head and neck squamous cell carcinoma].
Bron L; Romero P
Rev Med Suisse; 2006 Oct; 2(81):2216-9. PubMed ID: 17076151
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
6. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
Yi H; Rong Y; Yankai Z; Wentao L; Hongxia Z; Jie W; Rongyue C; Taiming L; Jingjing L
Vaccine; 2006 Mar; 24(14):2575-84. PubMed ID: 16420967
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
8. A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck.
Freeman SM; Franco JL; Kenady DE; Baltzer L; Roth Z; Brandwein HJ; Hadden JW
Am J Clin Oncol; 2011 Apr; 34(2):173-8. PubMed ID: 20539208
[TBL] [Abstract][Full Text] [Related]
9. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
10. Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells.
Karcher J; Dyckhoff G; Beckhove P; Reisser C; Brysch M; Ziouta Y; Helmke BH; Weidauer H; Schirrmacher V; Herold-Mende C
Cancer Res; 2004 Nov; 64(21):8057-61. PubMed ID: 15520216
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
12. Pre-clinical safety evaluation of heat shock protein 65-MUC1 peptide fusion protein.
Huo Y; Li B; Zhang Y; Wang S; Bao M; Gao X; Li D; Wang L; Yu Y; Wang J
Regul Toxicol Pharmacol; 2007 Oct; 49(1):63-74. PubMed ID: 17600604
[TBL] [Abstract][Full Text] [Related]
13. Inhibition effects on liver tumors of BALB/c mice bearing H22 cells by immunization with a recombinant immunogen of GnRH linked to heat shock protein 65.
Zhang Y; Xu J; Zhao R; Liu J; Wu J
Vaccine; 2007 Sep; 25(39-40):6911-21. PubMed ID: 17728021
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in DNA vaccines for autoimmune diseases.
Silva CL; Bonato VL; dos Santos-Júnior RR; Zárate-Bladés CR; Sartori A
Expert Rev Vaccines; 2009 Feb; 8(2):239-52. PubMed ID: 19196203
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
[TBL] [Abstract][Full Text] [Related]
18. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
19. Effects of vaccination with heat shock proteins on streptozotocin induced diabetes in histidine decarboxylase knockout mice.
Szebeni A; Prohászka Z; Buzás E; Falus A; Kecskeméti V
Inflamm Res; 2008 Apr; 57(4):178-82. PubMed ID: 18351435
[TBL] [Abstract][Full Text] [Related]
20. Technology evaluation: Allovectin-7, Vical.
Galanis E
Curr Opin Mol Ther; 2002 Feb; 4(1):80-7. PubMed ID: 11883699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
